Source: Eur Respir J 2013; 41: 1091-1100
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Timothy J. Kidd, Kay A. Ramsay, Honghua Hu, Guy B. Marks, Claire E. Wainwright, Peter T. Bye, Mark R. Elkins, Philip J. Robinson, Barbara R. Rose, John W. Wilson, Keith Grimwood, Scott C. Bell, the ACPinCF Investigator Group. Shared Pseudomonas aeruginosa genotypes are common in Australian cystic fibrosis centres. Eur Respir J 2013; 41: 1091-1100

Member's Comments

No comment yet.

Related content which might interest you: Survey of Pseudomonas aeruginosa genotypes in colonised cystic fibrosis patients Source: Eur Respir J 2006 Oct 01;28(4):740-747 Year: 2006 Pseudomonas aeruginosa transmission is infrequent in New Zealand cystic fibrosis clinics Source: Eur Respir J 2008; 32: 1583-1590 Year: 2008 Cystic fibrosis infection with clonal strains of Pseudomonas aeruginosa: current knowledge and future management Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=105 Year: 2006 DNA fingerprinting of Pseudomonas aeruginosa (Pa) in cystic fibrosis patients: risk assessment of cross-colonisation in a CF revalidation centre Source: Eur Respir J 2002; 20: Suppl. 38, 208s Year: 2002 Molecular genetic characteristics of Pseudomonas aeruginosa strains isolated from children with cystic fibrosis in Moscow. Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021 Pseudomonas aeruginosa in the home environment of newly infected cystic fibrosis patients Source: Eur Respir J 2008; 31: 822-829 Year: 2008 DNA fingerprinting of pseudomonas aeruginosa in cystic fibrosis patients: risk assessment of cross-infection in a CF centre Source: Eur Respir J 2002; 20: Suppl. 38, 208s Year: 2002 Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units Source: Eur Respir J 2004; 24: 101-106 Year: 2004 Newly acquired pseudomonas aeruginosa in Belgian cystic fibrosis-patients: does the patients‘ P. aeruginosa genotype correlate with environmental genotypes? Source: Eur Respir J 2006; 28: Suppl. 50, 485s Year: 2006 Epidemiology of Pseudomonas aeruginosa in a cystic fibrosis rehabilitation centre Source: Eur Respir J 2005; 25: 474-481 Year: 2005 Cystic fibrosis patients and families support cross-infection measures Source: Eur Respir J 2004; 24: 449-452 Year: 2004 Typing of pseudomonas aeruginosa with random amplified polymorphic DNA; a study of molecular typing and antibiotic resistance of hospitalized patients in NRITLD Source: Eur Respir J 2006; 28: Suppl. 50, 523s Year: 2006 Molecular epidemiological analysis suggests cross-infection with Pseudomonas aeruginosa is rare in non-cystic fibrosis bronchiectasis Source: Eur Respir J 2014; 43: 900-903 Year: 2014 Detection of Pseudomonas aeruginosa infection in cystic fibrosis patients by eNose technology Source: International Congress 2018 – Latest developments in cystic fibrosis Year: 2018 Inflammatory markers in cystic fibrosis patients with transmissible Pseudomonas aeruginosa Source: Eur Respir J 2003; 22: 503-506 Year: 2003 Achromobacter xylosoxidans strains with shared genotype among patients attending a cystic fibrosis (CF) rehabilitation centre Source: Eur Respir J 2005; 26: Suppl. 49, 596s Year: 2005 Variability of ß-lactamase resistance Pseudomonas aeruginosa genes infecting patients with cystic fibrosis Source: Virtual Congress 2021 – Back to infection basics Year: 2021 Evaluating the Leeds criteria for Pseudomonas aeruginosa infection in a cystic fibrosis centre Source: Eur Respir J 2006; 27: 937-943 Year: 2006 Achromobacter (A.) xylosoxidans in cystic fibrosis: prevalence and clinical relevance Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle Year: 2005 Factors associated with infection by Pseudomonas aeruginosa in adult cystic fibrosis Source: Eur Respir J 2005; 26: 651-656 Year: 2005